glp 1 approved for mash 🔴We now have two FDA-approved drugs MASLD/MASH: 🔸 Resmetirom (oral, THR-β agonist) 🔹 Semaglutide (weekly SC, GLP-1 RA) side-by-side comparison, courtesy of @rabataller #MASLD #MASH #FattyLiver @_ILTS_ @EASLedu @AASLDtweets @novonordisk GLP-1 BREAKTHROUGH: FDA APPROVES TREATMENT

(2003) Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimers disease

Summary: There is no authorised UK reconstitution ratio for retatrutide, as it remains an unlicensed investigational compound with no approved MHRA guidance, SmPC, or NHS prescribing pathway

[5] The methylation cycle hypothesis states that many if not all of the symptoms of CFS are caused by errors in the genes that regulate or have a strong impact on one-carbon metabolism, such as MTHFR, CBS, DHPR, MTRR, or MAO-A

Pratter on May 17

Fibroblast growth factor receptor signaling in metabolic dysfunction-associated fatty liver disease: Pathogenesis and therapeutic targets